Global-Med Technologies Group, Inc. Sarasota, FL - 34236

Global-Med Technologies Group, Inc. is categorized under Medical Research in Sarasota, FL and active since 2008.

Global-Med Technologies Group, Inc. was established in 2008, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number by the NAICS.

If you are seeking more information, feel free to contact Connie Konsler at the company’s headquarters by writing to 443F John Ringling Blvd., Sarasota, Florida FL 34236 or by phoning (941) 388-1881. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Global-Med Technologies Group, Inc.
Contact Person: Connie Konsler
Address: 443F John Ringling Blvd., Sarasota, Florida 34236
Phone Number: (941) 388-1881
Website Address: global-med.us.com
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 2008
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Medical Research
Share This Business:

Global-Med Technologies Group, Inc. was started in 2008 to provide professional Medical Research under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Connie Konsler for inquiries that concern Global-Med Technologies Group, Inc. by calling the company number (941) 388-1881, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Global-Med Technologies Group, Inc. can be found at the coordinates 27.318971146616,-82.577 as well as the street address 443F John Ringling Blvd. in Sarasota, Florida 34236.

For its online presence, you may visit Global-Med Technologies Group, Inc.’s website at global-med.us.com and engage with its social media outlets through on Twitter and on Facebook.